March 21, 2015The Umstead Hotel and SpaCary, North Carolina

Duke Debates:Controversies In The Management of Gastrointestinal Malignancies

THE DUKE CANCER NETWORK in conjuction with THE DUKE CANCER INSTITUTE PRESENTS

Du

ke D

ebat

es:

Con

trov

ersi

es In

The

Man

agem

ent

of

Gas

troi

ntes

tinal

Mal

igna

ncie

s

Mar

ch 2

1, 2

015

REG

ISTR

ATI

ON

Reg

iste

r on

line

at h

ttp

://g

oo

.gl/

b4p

faH

$150

MD

$10

0 nu

rse/

fello

w/m

idle

vel

$60

0 in

dust

ry

CO

NTA

CT/

QU

ESTI

ON

S Fo

r qu

estio

ns, p

leas

e co

ntac

t:Be

th T

anne

r at

919

-681

-986

9 or

be

th.t

anne

r@dm

.duk

e.ed

u

HO

TEL

The

Um

stea

d H

ote

l an

d S

pa

100

Woo

dlan

d Po

nd D

rive

Phon

e: 9

19-4

47-4

00

0 C

ary,

NC

275

13

Toll-

free

: 866

-877

-414

1

THE

DU

KE

CA

NC

ER N

ETW

OR

K IN

CO

NJU

CTI

ON

WIT

H

THE

DU

KE

CA

NC

ER IN

STIT

UTE

PR

ESEN

TS

Duk

e C

ance

r N

etw

ork

DU

MC

332

6 D

urha

m, N

C 2

7710

Non

pro

fit O

rg.

U.S

. Pos

tage

PAID

Dur

ham

NC

Perm

it #6

0

Sponsored by the Duke University School of Medicine.

OVERVIEWLearn the most recent innovations in the treatment of gastroesopha-geal cancer, pancreatic cancer, neuroendocrine cancer and colorectal cancer. Discuss the technical aspects of challenging treatment with expert faculty.

AUDIENCEThis program is designed to meet the continuing education needs of oncologists, physician extenders, and allied health professionals.

LEARNING OBJECTIVES• Discuss multidisciplinary approaches for the management of

gastroesophageal cancer

• Discuss multidisciplinary approaches for treatment of neuroendocrine cancers

• Discuss multidisciplinary approaches for treatment of localized and advanced pancreatic cancer

• Identify molecular testing strategies and approaches for treatment of metastatic colorectal cancer

7:30 am Registration/Breakfast

8:00 am Welcome

8:05 am Key Note Speaker: Metastatic Pancreatic Cancer: Have Our Trials Failed Us or Have We Failed Our Patients? Jordan Berlin, MD, Ingram

Professor of Cancer Research, Vanderbilt University

9:00 am Case Presentation with Audience Response

9:10 am DEBATE: Management of Resected Gastroesophageal Cancer Hope Uronis, MD* vs.

Niharika Mettu, MD, PhD*

10:00 am Break

10:15 am Controversies and Challenges in GI Pathology for the Medical Oncologist Shannon McCall, MD*

11:05 am Case Presentation with Audience Response

11:15 am DEBATE: How I Treat Asymptomatic, Advanced Neuroendocrine Cancer Michael Morse, MD, MHS*

vs. Gerard Blobe, MD, PhD*

12:05 pm Lunch

1:05 pm Case Presentation with Audience Response

1:15 pm DEBATE: Is There a Role for Radiation in Localized Pancreatic Cancer? James Abbruzzese, MD*

vs. Brian Czito, MD*

2:05 pm Case Presentation with Audience Response

2:15 pm DEBATE: Is There a Role for HIPEC in Colorectal Cancer? Dan Blazer III, MD* vs.

David Hsu, MD, PhD*

3:05 pm Break

3:20 pm Case Presentation with Audience Response

3:30 pm Panel Discussion: Challenging Case of Colorectal Cancer Drs. Herbert Hurwitz*, John

Strickler* and Ivy Altomare*

4:20 pm Conclusion

*Duke University Faculty

Course Co-Directors

S. Yousuf Zafar, MD, MHS Assistant Professor of Medicine, Duke University Health System

Ivy Altomare, MD Associate Professor of Medicine, Duke University Health System

Linda Sutton, MD Associate Professor of Medicine, Medical Director, Duke Cancer Network Associate Chief Medical Officer, Duke Network Services

ACCREDITATION: In support of improving patient care, Duke Medicine is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Duke Medicine designates this live educational activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The CPE Review Panel has approved the proposed agenda “Duke Debates: Controversies in the Management of Gastrointestinal Malignancies” to be presented March 21, 2015 for 6.5 hours of credit. Your Program ID# is NCNC03211504

RESOLUTION OF CONFLICTS OF INTEREST: In accordance with the ACCME Standards for Commer-cial Support of CME, the Duke University School of Medicine will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

DISCLAIMER: The information provided at this CME activity is for continuing medical education purposes only and is not meant to substitute the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

COMMERCIAL SUPPORT: A complete list of supporters will be provided to attendees during the event.

Sponsored by the Duke University School of Medicine

AGENDA SATURDAY, MARCH 21, 2015